Stay updated with breaking news from Stuart Forbes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Late-breaking abstract on extended follow-up data from the MATCH Phase 2 trial accepted for poster presentation - - Poster presentation on new data highlighting the Company's discovery
Actively-managed ETFs have OCFs of 0.75%
The three vehicles are classified as Article 8 under SFDR
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time. Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time.
Inflammation can be both a superhero and a villain, depending on the context. Rather than eliminating it completely, new treatments are trying to redirect it.